BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18646178)

  • 1. Chemotherapeutic wafers for High Grade Glioma.
    Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
    Cochrane Database Syst Rev; 2008 Jul; (3):CD007294. PubMed ID: 18646178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy wafers for high grade glioma.
    Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007294. PubMed ID: 21412902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide for high grade glioma.
    Hart MG; Garside R; Rogers G; Stein K; Grant R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide for high grade glioma.
    Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
    Cochrane Database Syst Rev; 2008 Oct; (4):CD007415. PubMed ID: 18843749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image guided surgery for the resection of brain tumours.
    Barone DG; Lawrie TA; Hart MG
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009685. PubMed ID: 24474579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.
    Xing WK; Shao C; Qi ZY; Yang C; Wang Z
    Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS; Smith KA; Stea B
    World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
    Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
    Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative imaging technology to maximise extent of resection for glioma.
    Jenkinson MD; Barone DG; Bryant A; Vale L; Bulbeck H; Lawrie TA; Hart MG; Watts C
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012788. PubMed ID: 29355914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapeutic wafers in treatment of malignant cerebral glioma. Assessment of a Cochrane review].
    Kosteljanetz M; Poulsen HS
    Ugeskr Laeger; 2010 Jan; 172(3):214-7. PubMed ID: 20089214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam radiation dose escalation for high grade glioma.
    Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
    Cochrane Database Syst Rev; 2016 Aug; (8):CD011475. PubMed ID: 27541334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy versus resection for the management of low-grade gliomas.
    Jiang B; Chaichana K; Veeravagu A; Chang SD; Black KL; Patil CG
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD009319. PubMed ID: 28447767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.
    Lin SH; Kleinberg LR
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):343-59. PubMed ID: 18366283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
    Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009411. PubMed ID: 23784872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliadel therapy given for first resection of malignant glioma: a single centre study of the potential use of Gliadel.
    Whittle IR; Lyles S; Walker M
    Br J Neurosurg; 2003 Aug; 17(4):352-4. PubMed ID: 14579902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy versus resection for the management of low-grade gliomas.
    Veeravagu A; Jiang B; Ludwig C; Chang SD; Black KL; Patil CG
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009319. PubMed ID: 23633369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.